GSK
1,779.50 GBpChange from previous close: −0.86%Absolute change: −15.50 GBp
At a glance
- Revenue growth
- +4.11%
- 2025 vs 2024
- Net income growth
- +121.98%
- 2025 vs 2024
- Net margin
- 17.5%
- 2024: 8.2%
Financial data
Amounts in millions of GBP; per-share values in GBP; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total assets | 61,118 | 59,463 | 59,005 | 60,146 | 79,103 |
| Current assets | 17,510 | 16,997 | 18,644 | 20,769 | 18,674 |
| Cash and equivalents | 3,397 | 3,870 | 2,936 | 3,723 | 4,274 |
| Short-term investments | 9.0 | 21.0 | 42.0 | 67.0 | 614 |
| Receivables | 7,374 | 6,935 | 7,403 | 7,115 | 7,478 |
| Inventory | 5,924 | 5,669 | 5,498 | 5,146 | 5,783 |
| Net property, plant and equipment | 10,048 | 10,073 | 9,957 | 9,620 | 10,672 |
| Goodwill | 7,018 | 6,982 | 6,811 | 7,046 | 10,552 |
| Other intangible assets | 16,748 | 15,515 | 14,768 | 14,318 | 30,079 |
| Long-term investments | 1,126 | 1,196 | 1,192 | 1,541 | 2,276 |
| Current liabilities | 21,391 | 21,697 | 21,068 | 22,810 | 23,670 |
| Accounts payable | 3,535 | 3,462 | 3,718 | 3,866 | 4,535 |
| Long-term debt | 14,082 | 13,703 | 14,154 | 16,194 | 19,761 |
| Total debt | 17,720 | 16,986 | 18,018 | 20,987 | — |
| Total liabilities | 45,162 | 46,377 | 46,210 | 50,050 | 57,761 |
| Total equity (incl. minority) | 15,956 | 13,086 | 12,795 | 10,096 | 21,342 |
| Retained earnings | 10,957 | 8,767 | 7,743 | 4,792 | 8,747 |
| Minority interest | -421 | -585 | -552 | -502 | 6,287 |